Position in NVO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$644,169
+$131,874 QoQ
Shares Held
13,437
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#638
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAX Financial Group, LLC holds $3,929,562 across 7 Drug Manufacturers - General names. NVO ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,103 | $1,322,971 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
13,437 | $644,169 | |
| 3 | JNJ |
Johnson & Johnson
|
2,114 | $536,892 | |
| 4 | ABBV |
AbbVie Inc.
|
2,019 | $508,061 | |
| 5 | AZN |
Astrazeneca PLC
|
2,504 | $474,808 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,794 | $226,653 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $644,169 | 13,437 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $512,295 | 13,940 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $379,208 | 7,453 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $462,897 | 8,342 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $498,876 | 7,228 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $702,663 | 10,119 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $464,508 | 5,400 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $619,878 | 5,206 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $913,678 | 6,401 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $852,832 | 6,642 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $745,667 | 7,208 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $676,593 | 7,440 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $633,402 | 3,914 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $635,923 | 3,996 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $641,376 | 4,739 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $630,757 | 6,331 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $718,500 | 6,448 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,041,093 | 9,375 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,109,024 | 9,902 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,007,144 | 10,490 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $914,600 | 10,918 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $692,470 | 10,271 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $590,302 | 8,451 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $561,688 | 8,090 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $466,021 | 7,117 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $381,186 | 6,332 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||